Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZNCF crawled time : 17:00 save search
Cervical Cancer Global Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
Published: 2024-03-01 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: -0.43%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.59%
H: 2.06%
C: 2.06%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.28%
H: 0.75%
C: 0.4%
review cancer trials global trial
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.63%
H: 0.8%
C: 0.75%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.8%
H: 0.14%
C: -0.89%
disease vaccine respiratory global set market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -2.93%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.31%
H: 0.39%
C: -0.44%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.18%
H: 0.5%
C: -0.46%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.58%
C: 0.05%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.34%
H: 1.02%
C: 0.59%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.04%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.06%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.24%
H: 2.03%
C: 1.49%
patent report global market
Global Respiratory Syncytial Virus (RSV) Vaccine and Antibody Pipeline Market Forecasts to 2030
Published: 2023-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.27%
H: 0.38%
C: -0.54%
antibody vaccine respiratory pipeline global virus market
Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide
Published: 2023-09-08 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -0.1%
IPIX | $0.0101 92.86% 230K
|
Manufacturing
|
| O: 0.0%
H: 1.19%
C: 0.6%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
CPIX | $1.65 6.02% 790
|
Health Technology
|
| O: -2.99%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.49%
H: 0.24%
C: -0.16%
global
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published: 2023-01-30 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.09%
H: 2.18%
C: -1.43%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.19%
H: 0.13%
C: -0.69%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.0%
H: 0.79%
C: -0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: -3.53%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.13%
H: 0.78%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.3%
H: 0.06%
C: -0.81%
global report gastrointestinal therapeutics market
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Need of Potential Treatments to Improve Quality of Life Drives Sector
Published: 2022-12-22 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.06%
H: 1.27%
C: 0.93%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.04%
H: 0.32%
C: 0.31%
lung global report life potential cancer market
The Worldwide mRNA Therapeutics Industry is Expected to Reach $37.7 billion by 2030
Published: 2022-12-15 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.14%
H: 0.4%
C: -1.41%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: -1.16%
H: 1.17%
C: -3.23%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.64%
H: 2.33%
C: -0.17%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -1.39%
H: 1.41%
C: -4.24%
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -2.23%
H: 2.67%
C: -3.2%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 1.45%
C: -2.28%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.58%
H: 0.11%
C: -0.41%
expected mrna therapeutics
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Published: 2022-12-06 (Crawled : 17:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: -0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.64%
H: 0.04%
C: -2.12%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.49%
H: 0.12%
C: -2.25%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -2.98%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.11%
H: 0.02%
C: -1.74%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.48%
H: 1.59%
C: 0.69%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.33%
H: 0.56%
C: -0.89%
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Bronchitis Treatments: Global Markets
Published: 2022-11-07 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.13%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.01%
H: 0.88%
C: 0.88%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.58%
H: 0.0%
C: -2.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.77%
H: 1.12%
C: 0.89%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -3.09%
H: 0.72%
C: -0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.11%
H: 0.49%
C: 0.07%
global
Fortress Biotech Announces Timing of Regular Monthly Dividend for October, November and December 2022 for its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.24%
H: 1.81%
C: 0.48%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.01%
H: 4.52%
C: 2.06%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.74%
H: 1.53%
C: 1.21%
biotech
Global Report on Europe precision medicine Market Size & Share Worth USD 27469 Million, to Record a 10.7% CAGR by 2028 | Europe precision medicine Industry Trends, Segmentation, Analysis & Forecast by Zion Market Research
Published: 2022-05-16 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.25%
H: 2.28%
C: 1.77%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.59%
H: 0.58%
C: -0.32%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
europe research report market
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published: 2022-04-12 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.86%
H: 1.21%
C: 1.21%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.16%
H: 0.22%
C: 0.22%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.48%
H: 0.09%
C: -0.68%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.77%
H: 0.99%
C: 0.49%
ALB | $112.15 0.31% -0.13% 2M
|
Process Industries
|
| O: 1.31%
H: 2.06%
C: -1.76%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.32%
H: 0.43%
C: -0.55%
report approval growth market drug
Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Published: 2022-04-01 (Crawled : 17:00) - biospace.com/
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: 1.86%
H: 0.0%
C: -1.42%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -4.03%
H: 3.34%
C: 3.13%
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 0.99%
H: 4.9%
C: 1.96%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.47%
H: 3.62%
C: 1.45%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 1.69%
H: 1.11%
C: -1.67%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.92%
H: 1.76%
C: 1.64%
biotech
Stroke Therapeutics Market to register a growth of USD 1.54 billion at a CAGR of 5% | High-risk Factors for Stroke is a Key Driver | Technavio
Published: 2022-02-10 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.35%
H: 4.64%
C: 1.43%
AMCR | $8.97 0.79% 0.0% 6.4M
|
Process Industries
|
| O: 0.09%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 2.11%
H: 3.46%
C: 0.76%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
risk therapeutics stroke growth
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.21%
H: 0.98%
C: 0.98%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
treatment cancer breast cancer merge
Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published: 2021-12-14 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: -1.42%
H: 0.02%
C: 0.02%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.44%
H: 5.82%
C: 1.91%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: -1.37%
H: 0.68%
C: 0.37%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.8%
H: 0.08%
C: -0.43%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.2%
H: 0.66%
C: -0.52%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.82%
H: 0.92%
C: 0.66%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 2.71%
H: 2.77%
C: 1.21%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.3%
H: 0.1%
C: -1.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: -0.82%
H: 0.38%
C: -2.71%
ENDP | $0.2926 -9.6%
|
Health Technology
|
| O: -5.76%
H: 7.53%
C: 0.47%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.31%
H: 0.7%
C: -0.63%
drug liver growing drug delivery
Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
Published: 2021-11-29 (Crawled : 17:00) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
ARTL | $1.28 -1.94% 5.5K
|
Health Technology
|
| O: 5.5%
H: 0.0%
C: -11.8%
financial results bioscience results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.